Uw huidige browser heeft updates nodig. Zolang u niet update zullen bepaalde functionaliteiten op de website niet beschikbaar zijn.
Let op: het geselecteerde rooster heeft overlappende bijeenkomsten.
Volgens onze gegevens heb je nog geen vakken behaald.
Je planning is nog niet opgeslagen
Let op! Uw planning heeft vakken in dezelfde periode met overlappend timeslot
Farmaco-economie (2025/2026: Periode 2)
Cursusdoel
After successfully completing this elective, the student can:
- Assess the quality and usefulness of pharmaoeconomic evaluations
- Independently set up and perform a pharmacoeconomic analysis
Sub-learning objectives:
After successfully completing this elective, the student can:
- Describe the reimbursement structure and financing of the Dutch health care system
- Describe the role and necessity of pharmacoeconomics in this system from the perspective of various stakeholders
- Explain the basic concepts of pharmacoeconomics
- Distinguish and name types of economic analyses
- Calculate transition probabilities and construct parametric survival curves
- Indicate which types of costs should be included in an economic analysis and how these costs should be measured and valued
- Indicate which effect measurements are relevant in an economic analysis
- Describe the difference between direct and indirect utility measurement
- Calculate incremental cost-effectiveness or cost-utility ratios
- Explain the principle of discounting
- Perform calculations to discount costs and effects
- Explain the importance of sensitivity analysis
- Perform a one-way and a probabilistic sensitivity analysis and scenario analysis
- Distinguish the main types of models
- Build and analyze a cost-utility model, including sensitivity analyses, time-dependent transition probabilities and extrapolation of survival data.
Vakinhoudelijk
- There is a lot of international scientific literature that can function as examples and comparative material.
- In this way, the students learn to better understand literature in this field.
- The students learn to articulate an investigation briefly, concisely and accurately.
In addition to the article, the project assignment is also shared with peers via a group presentation. Ultimately, on the basis of the articles produced, the knowledge and understanding of individual students will be tested in an oral exam. The oral can include all material taught throughout the course.
Werkvormen
Hoor/werkcollege
Inzage
Practicum
Toetsing
Eindresultaat
Verplicht | Weging 100% | ECTS 7,5
The knowledge and skills acquired within the pharmacoeconomics block are tested by means of a group assignment (50%) and an oral test (50%). Both results should be higher than 5.5 to pass the course.
Ingangseisen en voorkennis
Ingangseisen
Je moet inschreven staan voor de volgende opleiding:
- Farmacie
Voorkennis
• Basic understanding about Markov models • Basic knowledge about quality assessment of pharmaco-economic evaluations • Basic understanding of the Dutch healthcare system Ook studenten die niet voor de masters Farmacie of Drug Innovation staan ingeschreven kunnen een aanvraag doen bij de contactpersoon, welke individueel wordt beoordeeld.
Voorkennis kan worden opgedaan met
FA-MA105
Voertalen
- Engels
Cursusmomenten
Gerelateerde studies
Tentamens
Er is geen tentamenrooster beschikbaar voor deze cursus
Verplicht materiaal
Er is geen informatie over de verplichte literatuur bekend
Aanbevolen materiaal
-
SOFTWAREMicrosoft Office Professional Plus 2010 (beschikbaar in MyWorkPlace) R for Windows (beschikbaar in MyWorkPlace)
Coördinator
| J. Stoelinga MSc | j.stoelinga@uu.nl |
Docenten
Inschrijving
Inschrijving
Van maandag 15 september 2025 tot en met vrijdag 26 september 2025
Inschrijving niet geopend
Permanente link naar de cursuspagina
Laat in de Cursus-Catalogus zien
Laat in MyTimetable zien
klikt, stop je een vak in je rugzak, zodat je dit vak door de rest van de CursusPlanner mee kunt nemen.